Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC

Jiangsu Cancer Institute & Hospital · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
efficacyesophageal-squamous-cell-carcinoma
esophageal squamous cell carcinoma, tislelizumab, chemoradiation, escc, conversion therapy, safty, efficacy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 980709
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.